Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Harvard Business School
Colorcon
Express Scripts

Last Updated: August 11, 2022

HEPARIN SODIUM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for heparin sodium and what is the scope of freedom to operate?

Heparin sodium is the generic ingredient in thirty-eight branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Akorn, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Fresenius Kabi Usa, Gland, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, West-ward Pharms Int, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, and 3M, and is included in eighty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for heparin sodium. Seventeen suppliers are listed for this compound.

Summary for HEPARIN SODIUM
Drug Prices for HEPARIN SODIUM

See drug prices for HEPARIN SODIUM

Recent Clinical Trials for HEPARIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fayoum University HospitalN/A
The George InstitutePhase 2/Phase 3
Royal North Shore HospitalPhase 2/Phase 3

See all HEPARIN SODIUM clinical trials

Pharmacology for HEPARIN SODIUM

US Patents and Regulatory Information for HEPARIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold HEPARIN LOCK FLUSH heparin sodium INJECTABLE;INJECTION 089064-001 Oct 9, 1985 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fresenius Kabi Usa HEPARIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 017029-010 Apr 28, 1986 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Gland HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 205323-002 Nov 18, 2019 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fresenius Kabi Usa HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 017029-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Johnson and Johnson
Boehringer Ingelheim
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.